3-((4-Methylpiperazin-1-yl)methyl)benzonitrile
95%
- Product Code: 80993
CAS:
859850-90-1
| Molecular Weight: | 215.29 g./mol | Molecular Formula: | C₁₃H₁₇N₃ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | 334.2±27.0°C | |
| Density: | Storage Condition: | 2-8°C |
Product Description:
This compound is primarily utilized in the pharmaceutical industry as a key intermediate in the synthesis of various biologically active molecules. It is particularly significant in the development of receptor antagonists and enzyme inhibitors, which are crucial for treating neurological and psychiatric disorders. Its structural features, including the piperazine ring and benzonitrile moiety, make it a versatile building block for designing compounds with potential therapeutic effects. Researchers often employ it in medicinal chemistry to optimize drug candidates for improved efficacy and selectivity. Additionally, it may be explored in the development of targeted therapies for conditions such as cancer, where modulation of specific pathways is required.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.250 | 10-20 days | £47.83 |
+
-
|
| 1.000 | 10-20 days | £98.11 |
+
-
|
3-((4-Methylpiperazin-1-yl)methyl)benzonitrile
This compound is primarily utilized in the pharmaceutical industry as a key intermediate in the synthesis of various biologically active molecules. It is particularly significant in the development of receptor antagonists and enzyme inhibitors, which are crucial for treating neurological and psychiatric disorders. Its structural features, including the piperazine ring and benzonitrile moiety, make it a versatile building block for designing compounds with potential therapeutic effects. Researchers often employ it in medicinal chemistry to optimize drug candidates for improved efficacy and selectivity. Additionally, it may be explored in the development of targeted therapies for conditions such as cancer, where modulation of specific pathways is required.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
£0.00
£0.00
Total :